Meanwhile, the higher expression levels of GALNTL4 seem to be associated with a poor survival probability in colon adenocarcinoma (p = 0.385) and stomach adenocarcinoma patients (p = 0.088), respectively; however, the correlation was also not statistically significant (Figure S7d,f). This evidence concerns the gene GALNT18 and colon adenocarcinoma.